Back to search
Epilepsy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Epilepsy trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Epilepsy trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
ENDEAVOR is a Phase 1/2, 2-part, multicenter study to evaluate the safety and efficacy of ETX101 in participants with SCN1A-positive Dravet syndrome aged ≥6 to…
Drug-resistant focal epilepsy is a severe neurological disease that affects one-third of patients with epilepsy. Surgery is the only potentially curative treatm…
This observational natural history study will follow individuals with MEHMO (Mental disability, Epileptic seizure, Hypopituitarism/Hypogenitalism, Microcephaly,…
The goal of this multi-site clinical trial is to determine the effectiveness of two components of a web-based intervention (Epilepsy Journey) to improve executi…
The goal of this clinical trial is to learn if cannabidiol ("CBD-oil") works to treat severe epilepsy in children. It will also learn about the safety of cannab…
This is a clinical research study for an investigational drug called RAP-219 in adult participants with focal seizures. This study is being conducted to determi…
This self-crossover, randomized controlled, pilot study aims to collect clinical data of bilateral stimulation of subthalamic nucleus (STN) combined with centro…
This study will monitor for potential chronic liver injury and liver fibrosis, in participants treated with cannabidiol oral solution.